|
View results for a demographic group: |
Select a different topic: |
| View results for a different geographical area: |
|
| Total Respond.^ |
No Use | Use single product | Use multiple products | |||||||
|---|---|---|---|---|---|---|---|---|---|---|
| N | % | C.I.(95%) | N | % | C.I.(95%) | N | % | C.I.(95%) | ||
| TOTAL | 4,248 | 3,460 | 79.3 | 77.6-80.8 | 663 | 17.2 | 15.8-18.8 | 125 | 3.5 | 2.8- 4.3 |
| GENDER | ||||||||||
| Male | 1,923 | 1,493 | 74.8 | 72.2-77.2 | 355 | 20.8 | 18.6-23.3 | 75 | 4.4 | 3.3- 5.7 |
| Female | 2,325 | 1,967 | 83.1 | 80.9-85.2 | 308 | 14.1 | 12.2-16.3 | 50 | 2.7 | 1.9- 3.8 |
| Have Health Insurance | ||||||||||
| Yes | 3,755 | 3,096 | 80.3 | 78.5-82.0 | 562 | 16.6 | 15.1-18.3 | 97 | 3.0 | 2.4- 3.8 |
| No | 422 | 309 | 69.2 | 63.3-74.6 | 86 | 22.9 | 18.2-28.3 | 27 | 7.9 | 4.9-12.6 |
| Body Mass Index | ||||||||||
| Underweight | 49 | *** | *** | *** | *** | *** | *** | *** | *** | *** |
| Recommended Range | 1,088 | 877 | 77.5 | 73.8-80.9 | 177 | 18.9 | 15.7-22.5 | 34 | 3.6 | 2.4- 5.4 |
| Overweight | 1,330 | 1,070 | 78.9 | 76.0-81.5 | 220 | 17.1 | 14.8-19.8 | 40 | 4.0 | 2.8- 5.7 |
| Obese | 1,426 | 1,161 | 79.7 | 76.9-82.2 | 219 | 16.8 | 14.5-19.4 | 46 | 3.5 | 2.5- 5.0 |
| Current Smoker | ||||||||||
| Yes | 564 | *** | *** | *** | 452 | 77.5 | 72.8-81.7 | 112 | 22.5 | 18.3-27.2 |
| No | 3,664 | 3,441 | 92.2 | 90.9-93.4 | 210 | 7.4 | 6.2- 8.7 | *** | *** | *** |
| History of CVD** | ||||||||||
| Yes | 485 | 376 | 77.3 | 72.2-81.7 | 98 | 20.4 | 16.2-25.3 | *** | *** | *** |
| No | 3,718 | 3,049 | 79.6 | 77.8-81.3 | 556 | 16.8 | 15.2-18.5 | 113 | 3.6 | 2.9- 4.5 |
| Binge Drinker | ||||||||||
| Yes | 556 | 374 | 63.0 | 58.0-67.8 | 143 | 29.0 | 24.6-33.8 | 39 | 8.0 | 5.6-11.4 |
| No | 3,490 | 2,918 | 82.0 | 80.2-83.7 | 492 | 15.3 | 13.7-17.0 | 80 | 2.8 | 2.1- 3.6 |
| Heavy Drinker | ||||||||||
| Yes | 210 | 139 | 61.2 | 53.0-68.7 | 52 | 27.6 | 20.9-35.5 | 19 | 11.2 | 6.7-18.1 |
| No | 3,830 | 3,150 | 80.1 | 78.3-81.8 | 581 | 16.8 | 15.2-18.5 | 99 | 3.1 | 2.5- 3.9 |
| COPD | ||||||||||
| Yes | 330 | 204 | 56.6 | 48.5-64.4 | 106 | 36.5 | 29.0-44.8 | 20 | 6.9 | 3.9-11.9 |
| No | 3,903 | 3,243 | 81.2 | 79.5-82.7 | 555 | 15.6 | 14.2-17.1 | 105 | 3.2 | 2.6- 4.0 |
| Current Asthma | ||||||||||
| Yes | 370 | 287 | 73.8 | 66.8-79.7 | 66 | 20.3 | 14.9-27.0 | 17 | 5.9 | 3.3-10.4 |
| No | 3,868 | 3,165 | 79.8 | 78.0-81.4 | 595 | 17.0 | 15.4-18.6 | 108 | 3.3 | 2.6- 4.1 |
| Diabetes | ||||||||||
| Yes | 607 | 509 | 84.2 | 80.1-87.5 | 94 | 15.1 | 11.8-19.0 | *** | *** | *** |
| No | 3,639 | 2,950 | 78.5 | 76.7-80.3 | 569 | 17.6 | 16.0-19.3 | 120 | 3.9 | 3.1- 4.8 |
| Functional Disability | ||||||||||
| Yes | 1,359 | 1,035 | 74.4 | 71.1-77.3 | 266 | 20.3 | 17.6-23.3 | 58 | 5.3 | 3.9- 7.2 |
| No | 2,861 | 2,404 | 81.5 | 79.5-83.3 | 391 | 15.9 | 14.1-17.8 | 66 | 2.6 | 2.0- 3.6 |
| Has two or more chronic diseases† | ||||||||||
| Yes | 1,374 | 1,087 | 77.9 | 74.8-80.6 | 245 | 18.6 | 16.0-21.4 | 42 | 3.6 | 2.5- 5.1 |
| No | 2,874 | 2,373 | 79.8 | 77.8-81.8 | 418 | 16.7 | 14.9-18.6 | 83 | 3.5 | 2.7- 4.5 |
*Current use of cigarettes, e-cigarettes, smokeless tobacco, cigars, or hookah.
This table only includes respondents who were asked the questions on other tobacco products.
**History of cardiovascular disease includes history of heart attack or coronary heart disease or stroke.
†Chronic diseases include heart disease (heart attack/stoke/angina), current asthma, skin cancer, other cancer, COPD, arthritis, depression, kidney disease and diabetes.
PLEASE NOTE: Due to changes in the weighting methodology and other factors, results from 2021 are NOT comparable to 2010
and earlier years.
***The estimate was suppressed because it did not meet statistical reliability standards. See BRFSS 2021 Annual Results Technical Notes for more details.
^Use caution in interpreting cell sizes less than 50, % = Percentage, C.I.(95%) = Confidence Interval (at 95 percent probability level).
Percentages are weighted to population characteristics and therefore cannot be calculated exactly from the numbers in this table.
BRFSS Home | Annual Questionnaires | Technical Notes
This page was generated on 19AUG22.
FOLLOW US